Tumor heterogeneity as prognostic factor in patients with low-stage (T1-3N0M0) renal-cell carcinoma.
van der Poel
H G
HG
Department of Urology, University Hospital, Nijmegen, The Netherlands.
Mulders
P F
PF
Oosterhof
G O
GO
Schaafsma
H E
HE
Hendriks
J C
JC
Schalken
J A
JA
Debruyne
F M
FM
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002292:Carcinoma, Renal Cell / Q000401:mortality / Q000473:pathology*; D002467:Cell Nucleus / Q000473:pathology*; D048429:Cell Size; D018450:Disease Progression; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D017567:Karnofsky Performance Status; D007680:Kidney Neoplasms / Q000401:mortality / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009367:Neoplasm Staging; D011379:Prognosis; D016016:Proportional Hazards Models; D016019:Survival Analysis; D015431:Weight Loss
D006454:Hemoglobins